JSPR - Jasper Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 175.42M
Enterprise value 49.46M
Trailing P/E 0.53
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.43
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.96

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-36.44%
S&P500 52-week change 314.65%
52-week high 33.8000
52-week low 30.3860
50-day moving average 31.5204
200-day moving average 31.3422

Share statistics

Avg vol (3-month) 3647.61k
Avg vol (10-day) 3183.55k
Shares outstanding 5110.33M
Implied shares outstanding 6N/A
Float 849.47M
% held by insiders 17.91%
% held by institutions 138.78%
Shares short (14 May 2023) 41.05M
Short ratio (14 May 2023) 42.48
Short % of float (14 May 2023) 41.07%
Short % of shares outstanding (14 May 2023) 40.95%
Shares short (prior month 13 Apr 2023) 43.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.85%
Return on equity (ttm)-51.46%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -51.33M
Net income avi to common (ttm)-49.74M
Diluted EPS (ttm)-1.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)129.4M
Total cash per share (mrq)1.17
Total debt (mrq)3.44M
Total debt/equity (mrq)2.75
Current ratio (mrq)16.79
Book value per share (mrq)1.14

Cash flow statement

Operating cash flow (ttm)-41.98M
Levered free cash flow (ttm)-25.84M